Intratumoral and s.c. injection of inactivated hemagglutinating virus of Japan envelope (GEN0101) in metastatic castration‐resistant prostate cancer

Inactivated hemagglutinating virus of Japan envelope (HVJ‐E) has an antitumor effect and tumor immunity. We undertook an open‐label, phase I, dose‐escalation study in patients with castration‐resistant prostate cancer (CRPC) to determine the safety and efficacy of intratumoral and s.c. injection of...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Kazutoshi, Kato, Taigo, Hatano, Koji, Kawashima, Atsunari, Ujike, Takeshi, Uemura, Motohide, Imamura, Ryoichi, Okihara, Koji, Ukimura, Osamu, Miki, Tsuneharu, Nakajima, Toshihiro, Kaneda, Yasufumi, Nonomura, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226216/
https://www.ncbi.nlm.nih.gov/pubmed/32112659
http://dx.doi.org/10.1111/cas.14366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226216/
https://www.ncbi.nlm.nih.gov/pubmed/32112659
http://dx.doi.org/10.1111/cas.14366

Ejemplares similares